Florida medical tech company launches novel AI test for prostate cancer therapy
Fox News
Florida medical tech company ArteraAI developed the ArteraAI Prostate Test, called the "first-ever predictive test" for patients with localized prostate cancer. Fox News Digital spoke to its CEO.
Among the company’s solutions is the ArteraAI Prostate Test, described as the first of its kind for patients with localized prostate cancer. The ArteraAI Prostate Test offers the advantage of fast turnaround times, its CEO told Fox News Digital. "Artificial intelligence is going to revolutionize health care for the better." Advancements in AI could also support pathologists in interpreting biopsies, said one urologist. Melissa Rudy is health editor and a member of the lifestyle team at Fox News Digital.
For each patient, the test looks at two pieces of information: a biopsy of the cancerous tumor and certain clinical data, explained Dr. Andre Esteva, a California-based medical AI researcher who is the CEO of ArteraAI.
Clonazepam, popular anxiety-reducing drug, recalled nationwide for ‘possibly life-threatening’ error
The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the FDA said in the recall.